Registration Dossier

Data platform availability banner - registered substances factsheets

Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.

The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.

Diss Factsheets

Toxicological information

Skin sensitisation

Currently viewing:

Administrative data

Endpoint:
skin sensitisation: in vitro
Type of information:
experimental study
Adequacy of study:
key study
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2018

Materials and methods

Test guideline
Qualifier:
according to guideline
Guideline:
OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
Version / remarks:
Due to a HPLC error causing a delayed start of the sequence, the calibration sam-ples had to be moved from the beginning to the end of the analysis sequence to ensure measurement of the peptide samples in a timely manner. The deviation was assessed and signed by the study director on 30. Jan. 2018.
Deviations:
yes
Remarks:
see remarks
GLP compliance:
yes (incl. QA statement)
Type of study:
direct peptide reactivity assay (DPRA)

Test material

Constituent 1
Chemical structure
Reference substance name:
1,1,1-trichloro-2-methyl-2-propanol hemihydrate
Cas Number:
6001-64-5
Molecular formula:
C4H7Cl3O H2O
IUPAC Name:
1,1,1-trichloro-2-methyl-2-propanol hemihydrate
Test material form:
solid: crystalline
Details on test material:
transparent and crystalline solid at ambient temperature

In vitro test system

Details on the study design:
The direct peptide reactivity assay (DPRA) is an in chemico assay to quantify the reactivity of the test item towards cysteine and lysine containing peptides. This reactivity is related to the skin sensitisation potential. This study was performed in order to estimate the skin sensitisation potential of Chlorobutanol Hemihydrate using a peptide model. To quantify the sensitisation potential, the depletion of the cysteine and lysine containing peptides caused by known amounts of the test item was measured using HPLC. The assay was used for supporting the discrimination between skin sensitizers (i.e. UN GHS Category 1) and non-sensitizers in accordance with the UN GHS. A categorization in the sub-categories 1 A and 1 B is not possible.

Results and discussion

In vitro / in chemico

Resultsopen allclose all
Run / experiment:
other: Cysteine
Parameter:
other: Cys-peptide depletion [%]
Value:
2.77
Vehicle controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of skin sensitisation
Run / experiment:
other: Lysine
Parameter:
other: Lys-Peptide depletion [%]
Value:
1.75
Vehicle controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of skin sensitisation
Key result
Run / experiment:
other: mean (Cysteine and Lysine)
Parameter:
other: Mean peptide depletion [%]
Value:
2.26
Vehicle controls validity:
valid
Positive controls validity:
valid
Remarks on result:
no indication of skin sensitisation

Any other information on results incl. tables

Table: Calculated peptide depletion values for the Lys-Peptide

Sample name

Depletion [%]

Single

Mean

Standard Deviation

Positive control Rep. 1

28.07

34.12

8.69

Positive control Rep. 2

30.21

Positive control Rep. 3

44.08

Test item Rep. 1

0.00

1.75

3.04

Test item Rep. 2

0.00

Test item Rep. 3

5.26

 

Table: Calculated peptide depletion values for the Cys-Peptide

Sample name

Depletion [%]

Single

Mean

Standard Deviation

Positive control Rep. 1

83.72

84.28

0.75

Positive control Rep. 2

85.13

Positive control Rep. 3

83.99

Test item Rep. 1

0.00

2.77

2.43

Test item Rep. 2

3.75

Test item Rep. 3

4.54

 

Applicant's summary and conclusion

Interpretation of results:
GHS criteria not met
Conclusions:
All acceptance criteria were fulfilled, therefore the test was considered valid. The DPRA prediction for the test item Chlorobutanol Hemihydrate was negative with reactivity class minimal according to the Cysteine 1:10/Lysine 1:50 prediction model.
No observations arousing doubts concerning the accuracy of the results and the validity of the study were made.
Executive summary:

The study was performed in order to evaluate the reactivity of the test item Chlorobutanol Hemihydrate towards cysteine (Cys-) and lysine (Lys-) containing peptides. A 100 mM test item in acetonitrile was incubated 24 ± 2 h at 25 °C together with cysteine and lysine peptides, respectively, and the peptide concentration after the incubation was measured using HPLC-UV.

Three replicates were prepared using 1:10 and 1:50 molar ratio of the test item with the Cys- and Lys-peptide, respectively. Triplicate samples of the solvent without test item were incubated and measured in parallel. The peptide depletion values after incubation are: 

Cys-peptide
depletion [%]

Lys-Peptide
depletion [%]

Mean peptide
depletion [%]

2.77

1.75

2.26

 According to the cysteine 1:10/lysine 1:50 prediction model, the DPRA predicition is “negative” with minimal reactivity.